At a hearing held on April 29, 2022, a six-member panel of the Second Circuit Court of Appeals in New York was asked by lawyers representing OxyContin manufacturer Purdue Pharma to approve the bankruptcy plan submitted earlier in the year, currently estimated to be...
On February 25, generic opioid manufacturer Johnson and Johnson and three major pharmaceutical distributors finalized a $26 billion deal that will settle around 3000 lawsuits filed by state and local governments in the ongoing opioid litigation, some of which have...
On December 30, after a six months-long trial, a New York jury found that Teva Pharmaceuticals contributed to the opioid crisis by creating a public nuisance in Suffolk and Nassau counties and New York State. Attributing 90% of the liability to Teva and its Anda Inc....
On December 16, U.S. District Judge Colleen McMahon issued a 142-page opinion ruling on the appeal brought by opponents to the Purdue Bankruptcy Plan that was approved in September, 2021 by Judge Robert D. Drain of the U.S. Bankruptcy Court for the Southern District...
Multiple appeals have been filed in the Purdue Pharma Chapter 11 bankruptcy case, centering on the issue of the releases being given to the members of the Sackler family that own Purdue. On September 21, United States Trustee William K. Harrington filed a motion...
In a major development in the ongoing opioid litigation involving the State of New York and Nassau and Suffolk counties, on September 9 defendant manufacturer Endo Pharmaceuticals settled for $50 million. Endo reached the settlement amidst allegations that the company...
There have been a number of developments on the opioid litigation front in the last week. Drugmaker Endo Pharmaceuticals and its lawyers from Arnold & Porter are battling allegations that they withheld damaging evidence from the parties by failing to respond to...
Opening statements in the sprawling opioids trial pursued by the state of New York and Nassau and Suffolk counties against seven defendant manufacturers and suppliers began on June 29 with four hours of presentations. The case is the first one involving opioids to be...
In a settlement reached on June 26, Johnson & Johnson agreed to pay up to $263 million to the state of New York and Nassau and Suffolk counties to resolve the plaintiffs’ claims that the pharmaceutical giant had contributed to the nationwide opioid crisis that has...
The first bellwether trial in the sprawling multidistrict opioid litigation began on May 3 in West Virginia federal court. The plaintiffs in the trial, Cabell County and the city of Huntington, West Virginia, which many consider the epicenter of the opioid drug...
